Skip to main content
WeightCited

Glutamine pour Obesity

C Preuves Preuves limitées issues de petites études, mais certains signaux positifs existent.

RCT (n=66) found 30 g/day reduced weight and waist circumference comparably to isonitrogenous protein control. Systematic review of 7 trials found improved inflammatory markers and gut barrier function in obese patients. Evidence is preliminary but growing, with benefits potentially mediated through the gut-metabolic axis.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dglutamine\u0026condition\u003Dobesity'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

En conclusion

RCT (n=66) found 30 g/day reduced weight and waist circumference comparably to isonitrogenous protein control. Systematic review of 7 trials found improved inflammatory markers and gut barrier function in obese patients. Evidence is preliminary but growing, with benefits potentially mediated through the gut-metabolic axis.

Key Study Findings

Other
[Nutrition in the prevention and healing of chronic wounds. Importance in improving the diabetic foot].
Dose: None vs: None Outcome: None Effet: None None

Population: chronic wounds and have been linked to delayed wound healing and dehiscence

Review
Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans.
Dose: None vs: None Outcome: None Effet: None None

Population: Humans (general)

Review
The Na+/Cl--Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic …
Dose: None vs: None Outcome: None Effet: None None

Population: Cancer patients (SLC6A14 transporter review)

Key Statistics

7

Études

300

Participants

Positive

C

Note

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
5-10 g/day
guthealth:
10-20 g/day
exerciserecovery:
5-10 g pre/post workout

Limite supérieure : 40 g/day (well-tolerated in clinical trials)

Posologies étudiées dans la recherche

Posologie Durée Effet N
None -- Positive --
None -- Mixed --
None -- Mixed --

Moment optimal de prise : Between meals or pre/post-exercise; may add to protein shakes

Safety & Side Effects

Effets indésirables signalés

  • Bloating
  • GI discomfort
  • Constipation

Interactions connues

  • Lactulose (may reduce effectiveness)
  • Anticonvulsants (may reduce effectiveness)

Apport maximal tolérable : 40 g/day (well-tolerated in clinical trials)

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Glutamine help with Obesity?
Based on 7 studies with 300 participants, there is limited but promising evidence that Glutamine may support Obesity management. Our evidence grade is C (Some Evidence).
How much Glutamine should I take for Obesity?
Studies have used various dosages. A commonly studied range is 5-10 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Glutamine?
Reported side effects may include Bloating, GI discomfort, Constipation. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Glutamine and Obesity?
We rate the evidence as Grade C (Some Evidence). This rating is based on 7 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

References

  1. [1] Guoyao Wu et al.. Adv Exp Med Biol. 2021. Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans. doi:10.1007/978-3-030-74180-8_10 PubMed
  2. [2] Rosa María Martínez García et al.. Nutr Hosp. 2021. [Nutrition in the prevention and healing of chronic wounds. Importance in improving the diabetic foot]. doi:10.20960/nh.03800 PubMed
  3. [3] Mohd Omar F Sikder et al.. AAPS J. 2017. The Na+/Cl--Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis. doi:10.1208/s12248-017-0164-7 PubMed

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.